La siguiente relación hace referencia a publicaciones de los últimos años, derivadas de proyectos de investigación parcialmente financiados por la Fundación.

  • Growth cartilage expression of growth hormone/insulin-like growth factor I axis in spontaneous and growth hormone induced catch-up growth. Iva Brito, Helena Gil Peña, Inés Molinos Norniella, Vanessa Loredo López, Tiago Henriques Coelho, Alberto Caldas Afonso. Growth Hormone IGF Research. 2012 Jun-Aug;22(3-4):129-33.
  • Growth Hormone Improves Growth Retardation Induced by Rapamycin without Blocking Its Antiproliferative and Antiangiogenic Effects on Rat Growth Plate. Alvarez-García O, García-López E, Loredo V, Gil-Peña H, Mejía-Gaviria N, Rodríguez-Suárez J, Ordóñez FÁ, Santos F.
    PLoS One. 2012;7(4):e34788.
  • Sirolimus and growth. Santos F, Álvarez García O, González D. Pediatr Transplant 2011; 15: 546-7
  • Growth of kidney-transplanted pediatric patients treated with sirolimus. Gonzalez D, García CD, Azócar M, Waller S, Alonso A, Ariceta G, Mejia N, Santos F. Pediatr Nephrol 2011; 26:961-6
  • Primary hyperoxaluria in a compound heterozygote infant. Mayordomo-Colunga J, Riverol D, Salido E, Santos F. World J Pediatr 2011; 7:173-75
  • Rapamycin induces growth retardation by disrupting angiogenesis in the growth plate. Alvarez-Garcia O, Garcia-Lopez E, Loredo V, Gil-Peña H, Rodriguez-Suarez J, Ordoñez F, Carbajo-Perez E, Santos F. Kidney Int 2010; 78:261-68
  • Improvement in growth after 1 year of growth hormone therapy in well-nourished infants with growth retardation secondary to chronic renal failure: results of a multicenter, controlled, randomized, open clinical trial. Santos F, Moreno ML, Neto A, Ariceta G, Vara J, Alonso A, Bueno, A, Afonso AC, Correia AJ, Muley R, Barrios V, Gómez C, Argente J. Clin J Am Soc Nephrol 2010; 5:1190-97
  • Genetic and clinical peculiarities in a new family with hereditary hypophosphatemic rickets with hypercalciuria: a case report. Mejia-Gaviria N, Gil-Peña H, Coto E, Pérez-Menéndez TM, Santos F. Orphanet Journal of rare Diseases 2010; 5:1
  • Longitudinal growth in chronic hypokalemic disorders. Gil-Peña H, Mejia N, Alvarez-Garcia O, Loredo V, Santos F. Pediatr Nephrol 2010; 25:733-37
  • Alterations of growth plate and abnormal insulin-like growth factor I metabolism in growth-retarded hypokalemic rats: effect of growth hormone treatment. Gil-Peña H, García-López E, Álvarez-García O, Loredo V, Carbajo-Pérez E, Ordóñez FA, Rodríguez-Suárez J, Santos F. Am J Physiol Renal Physiol 2009; 297:F639-45
  • Clinical and analytical findings in Gitelman's syndrome associated with homozygosity for the c.1925 G>A SLC12A3 mutation. Coto E, Arriba G, García-Castro M, Santos F, Corao AI, Díaz M, Sánchez Heras M, Basterrechea MA, Tallón S, Álvarez V. Am J Nephrol 2009; 30:218-21
  • Cinacalcet does not affect longitudinal growth but increases body weight gain in experimental uraemia. Nakagawa K, Pérez EC, Oh J, Santos F, Geldyyev A, Gross ML, Schaefer F, Schmitt CP. Nephrol Dial Transplant 2008;23:2761-67
  • The effect of fluoride on enamel and dentin formation in the uremic rat incisor. Lyaruu DM, Bronckers AL, Santos F, Mathias R, DenBesten P. Pediatr Nephrol. 2008; 23:1973-79
  • Urinary interleukin-6 is useful in distinguishing between upper and lower urinary tract infections. Rodríguez LM, Robles B, Marugán JM, Suárez A, Santos F. Pediatr Nephrol 2008; 23:429-33
  • Differential gene expression induced by growth hormone treatment in the uremic rat growth plate. Gil H, Lozano JJ, Alvarez-García O, Secades- Vázquez P, Rodríguez-Suárez J, García-López E, Carbajo Pérez E, Santos F. Growth Horm IGF Res 2008; 18: 353-59
  • Compound heterocygosis for intron 9 + 1 g > T and Leu850pro mutations in the SLC12A3 gene in Gitelman's syndrome. García Pérez A, Coto E, Santos F, Olea T, Caramelo C. Nefrologia 2008; 28: 659-60
  • High blood pressure due to aortic coarctation and renal artery stenosis in a teenager with type 1 neurofibromatosis. Pardo R, Somalo L, Málaga S, Santos F. Nefrologia 2008; 28:216-17
  • The Gitelman syndrome mutation, IVS9+1G>T, is common across Europe. Bouwer ST, Coto E, Santos F, Angelicheva D, Chandler D, Kalaydjieva L. Kidney Int 2007; 72:898
  • Hemolytic uremic syndrome by Streptococcus pneumoniae. Herrero-Morín JD, Fernández N, Santos F, Rey C, Málaga S. Nefrología 2007; 27: 505-08
  • Strontium oral load test in children with idiopathic hypercalciuria. Fernández P, Santos F, Sotorrío P, Mayordomo J, Ferrero L. Pediatr Nephrol 2007; 22:1303-07
  • Rapamycin retards growth and causes marked alterations in the growth plate of young rats. Álvarez-García O, Carbajo-Pérez E, García E, Gil H, Molinos I, Rodríguez J, Ordóñez FA, Santos F. Pediatr Nephrol 2007; 22:954-61
  • Distal RTA with nerve deafness: clinical spectrum and mutational analysis in five children. Gil H, Santos F, García E, Álvarez MV, Ordóñez FA,Málaga S, Coto E. Pediatr Nephrol 2007; 22:825-28
  • Administration of ghrelin to young uraemic rats increases food intake transiently, stimulates growth hormone secretion and does not improve longitudinal growth. Álvarez-García O, García-López E, Rodríguez J, Gil-Peña H, Molinos I, Carbajo-Pérez E, Santos F. Nephrol Dial Transplant 2007; 22:1309-13
  • A missense mutation in the chloride/proton ClC-5 antiporter gene results in increased expression of an alternative mRNA form that lacks exons 10 and 11. Identification of seven new CLCN5 mutations in patients with Dent's disease. Ramos-Trujillo E, González-Acosta H, Flores C, García-Nieto V, Guillén E, García S, Vicente C, Espinosa L, Maseda MA, Santos F, Camacho JA, Claverie-Martín F. J Hum Genet 2007; 52:255-61
  • Catch-up growth follows an abnormal pattern in experimental renal insufficiency and growth hormone treatment normalizes it. Molinos I, Santos F, Carbajo-Pérez E, García E, Rodríguez J, García-Alvarez O, Gil H, Ordoñez FA. Kidney int 2006; 70:1955-61.